

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of autophagic vacuole assembly (GO:2000785) | 5.55187369 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 5.54473702 |
| 3 | COPI coating of Golgi vesicle (GO:0048205) | 5.54473702 |
| 4 | regulation of vacuole organization (GO:0044088) | 4.85953659 |
| 5 | positive regulation of catecholamine secretion (GO:0033605) | 4.66620590 |
| 6 | synaptic vesicle maturation (GO:0016188) | 4.46389932 |
| 7 | macroautophagy (GO:0016236) | 4.26545416 |
| 8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.04783696 |
| 9 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.97534139 |
| 10 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.96147265 |
| 11 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.86639965 |
| 12 | regulation of phosphoprotein phosphatase activity (GO:0043666) | 3.85179460 |
| 13 | histone H3-K36 demethylation (GO:0070544) | 3.83195698 |
| 14 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.80504580 |
| 15 | sodium ion export (GO:0071436) | 3.70304871 |
| 16 | TOR signaling (GO:0031929) | 3.66086984 |
| 17 | NADH metabolic process (GO:0006734) | 3.60703889 |
| 18 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.57520214 |
| 19 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.52004573 |
| 20 | regulation of oxidative stress-induced neuron death (GO:1903203) | 3.48531173 |
| 21 | synaptic vesicle exocytosis (GO:0016079) | 3.45095085 |
| 22 | mannose metabolic process (GO:0006013) | 3.44729486 |
| 23 | potassium ion export (GO:0071435) | 3.41770826 |
| 24 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.38384660 |
| 25 | oxaloacetate metabolic process (GO:0006107) | 3.37994814 |
| 26 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.33631280 |
| 27 | locomotory exploration behavior (GO:0035641) | 3.32741047 |
| 28 | regulation of synaptic vesicle transport (GO:1902803) | 3.32469553 |
| 29 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.29750789 |
| 30 | alanine transport (GO:0032328) | 3.29427631 |
| 31 | regulation of ARF protein signal transduction (GO:0032012) | 3.28265920 |
| 32 | motile cilium assembly (GO:0044458) | 3.28063300 |
| 33 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.27670907 |
| 34 | negative regulation of macroautophagy (GO:0016242) | 3.24098119 |
| 35 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.18737667 |
| 36 | regulation of gamma-delta T cell activation (GO:0046643) | 3.16604712 |
| 37 | proline transport (GO:0015824) | 3.15420333 |
| 38 | coenzyme catabolic process (GO:0009109) | 3.13893451 |
| 39 | thymic T cell selection (GO:0045061) | 3.13868737 |
| 40 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.10089463 |
| 41 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.10089463 |
| 42 | cerebellar Purkinje cell layer development (GO:0021680) | 3.09203457 |
| 43 | positive regulation of nuclease activity (GO:0032075) | 3.08027378 |
| 44 | vesicle coating (GO:0006901) | 3.07688043 |
| 45 | regulation of oxidative phosphorylation (GO:0002082) | 3.05643575 |
| 46 | activation of protein kinase A activity (GO:0034199) | 3.00286868 |
| 47 | positive thymic T cell selection (GO:0045059) | 3.00003051 |
| 48 | neurotransmitter secretion (GO:0007269) | 2.99892766 |
| 49 | glutamate secretion (GO:0014047) | 2.97986285 |
| 50 | regulation of mast cell degranulation (GO:0043304) | 2.97022940 |
| 51 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.93865500 |
| 52 | transferrin transport (GO:0033572) | 2.93355028 |
| 53 | mast cell activation involved in immune response (GO:0002279) | 2.93007549 |
| 54 | mast cell degranulation (GO:0043303) | 2.93007549 |
| 55 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.91916409 |
| 56 | tricarboxylic acid metabolic process (GO:0072350) | 2.91842885 |
| 57 | positive regulation of synapse maturation (GO:0090129) | 2.91137157 |
| 58 | T cell selection (GO:0045058) | 2.90724075 |
| 59 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.90523131 |
| 60 | cellular potassium ion homeostasis (GO:0030007) | 2.90363383 |
| 61 | cellular response to zinc ion (GO:0071294) | 2.90001728 |
| 62 | activation of protein kinase B activity (GO:0032148) | 2.87109705 |
| 63 | negative regulation of cell killing (GO:0031342) | 2.86274399 |
| 64 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.86274399 |
| 65 | negative regulation of cell size (GO:0045792) | 2.83667972 |
| 66 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.83509184 |
| 67 | negative regulation of bone resorption (GO:0045779) | 2.82486726 |
| 68 | mast cell activation (GO:0045576) | 2.81170080 |
| 69 | diacylglycerol metabolic process (GO:0046339) | 2.80304556 |
| 70 | negative regulation of granulocyte differentiation (GO:0030853) | 2.79651017 |
| 71 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.79553541 |
| 72 | response to acidic pH (GO:0010447) | 2.79357141 |
| 73 | negative T cell selection (GO:0043383) | 2.78672778 |
| 74 | regulation of cholesterol homeostasis (GO:2000188) | 2.76680898 |
| 75 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.76569484 |
| 76 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.74683397 |
| 77 | trivalent inorganic cation transport (GO:0072512) | 2.74010368 |
| 78 | ferric iron transport (GO:0015682) | 2.74010368 |
| 79 | 2-oxoglutarate metabolic process (GO:0006103) | 2.73958780 |
| 80 | regulation of synapse structural plasticity (GO:0051823) | 2.73848276 |
| 81 | positive regulation of protein kinase C signaling (GO:0090037) | 2.73751908 |
| 82 | neuromuscular process controlling posture (GO:0050884) | 2.72806120 |
| 83 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.72697880 |
| 84 | regulation of granulocyte differentiation (GO:0030852) | 2.72462017 |
| 85 | regulation of nuclease activity (GO:0032069) | 2.72424937 |
| 86 | cellular response to interleukin-15 (GO:0071350) | 2.70079484 |
| 87 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.69834061 |
| 88 | regulation of leukocyte degranulation (GO:0043300) | 2.69748920 |
| 89 | negative thymic T cell selection (GO:0045060) | 2.69586078 |
| 90 | response to muscle activity (GO:0014850) | 2.68919074 |
| 91 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.68220678 |
| 92 | positive regulation of granulocyte differentiation (GO:0030854) | 2.68129726 |
| 93 | potassium ion import (GO:0010107) | 2.67388365 |
| 94 | cellular response to toxic substance (GO:0097237) | 2.67063861 |
| 95 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.66969970 |
| 96 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.65685923 |
| 97 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.65604468 |
| 98 | multicellular organism reproduction (GO:0032504) | 2.65572341 |
| 99 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 2.64855540 |
| 100 | lysine metabolic process (GO:0006553) | 2.64566385 |
| 101 | lysine catabolic process (GO:0006554) | 2.64566385 |
| 102 | regulation of defense response to virus by virus (GO:0050690) | 2.63957461 |
| 103 | relaxation of smooth muscle (GO:0044557) | 2.62845048 |
| 104 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.61766309 |
| 105 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.61766309 |
| 106 | mitochondrion degradation (GO:0000422) | 2.61282820 |
| 107 | cellular response to lithium ion (GO:0071285) | 2.61107945 |
| 108 | phosphatidylinositol dephosphorylation (GO:0046856) | 2.60982393 |
| 109 | negative regulation of interleukin-12 production (GO:0032695) | 2.60642043 |
| 110 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.60363893 |
| 111 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.60050205 |
| 112 | immunoglobulin mediated immune response (GO:0016064) | 2.59751655 |
| 113 | response to interleukin-15 (GO:0070672) | 2.59511806 |
| 114 | alpha-linolenic acid metabolic process (GO:0036109) | 2.59287123 |
| 115 | germinal center formation (GO:0002467) | 2.57577812 |
| 116 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.56595932 |
| 117 | phospholipid dephosphorylation (GO:0046839) | 2.56064491 |
| 118 | tricarboxylic acid cycle (GO:0006099) | 2.54805050 |
| 119 | positive regulation by symbiont of host defense response (GO:0052509) | 2.54632016 |
| 120 | modulation by symbiont of host defense response (GO:0052031) | 2.54632016 |
| 121 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.54632016 |
| 122 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.54632016 |
| 123 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.54632016 |
| 124 | modulation by symbiont of host immune response (GO:0052553) | 2.54632016 |
| 125 | neuromuscular process controlling balance (GO:0050885) | 2.52720198 |
| 126 | glycine transport (GO:0015816) | 2.52239794 |
| 127 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.51781996 |
| 128 | positive T cell selection (GO:0043368) | 2.51451626 |
| 129 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.49863504 |
| 130 | ER-nucleus signaling pathway (GO:0006984) | 2.48443608 |
| 131 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.48409409 |
| 132 | regulation of translational termination (GO:0006449) | 2.48164998 |
| 133 | negative regulation of organelle assembly (GO:1902116) | 2.47193862 |
| 134 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.46078825 |
| 135 | response to peptidoglycan (GO:0032494) | 2.45954414 |
| 136 | cellular response to unfolded protein (GO:0034620) | 2.45192352 |
| 137 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.44280137 |
| 138 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.43605409 |
| 139 | fatty acid homeostasis (GO:0055089) | 2.42477100 |
| 140 | leukocyte degranulation (GO:0043299) | 2.42037079 |
| 141 | negative regulation of autophagy (GO:0010507) | 2.41747795 |
| 142 | aspartate family amino acid catabolic process (GO:0009068) | 2.41429703 |
| 143 | regulation of ARF GTPase activity (GO:0032312) | 2.40900048 |
| 144 | neutral amino acid transport (GO:0015804) | 2.40102944 |
| 145 | regulation of regulated secretory pathway (GO:1903305) | 2.39473421 |
| 146 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.38513229 |
| 147 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.38504125 |
| 148 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.38125071 |
| 149 | dicarboxylic acid catabolic process (GO:0043649) | 2.37613126 |
| 150 | macrophage activation involved in immune response (GO:0002281) | 2.37503930 |
| 151 | response to type I interferon (GO:0034340) | 2.37224210 |
| 152 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.37076698 |
| 153 | myeloid cell activation involved in immune response (GO:0002275) | 2.36963224 |
| 154 | leukocyte aggregation (GO:0070486) | 2.36801070 |
| 155 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.36743985 |
| 156 | oligosaccharide biosynthetic process (GO:0009312) | 2.36589446 |
| 157 | regulation of beta-amyloid formation (GO:1902003) | 2.36094575 |
| 158 | L-serine transport (GO:0015825) | 2.35930400 |
| 159 | succinate metabolic process (GO:0006105) | 2.35926967 |
| 160 | positive regulation of histone deacetylation (GO:0031065) | 2.35539921 |
| 161 | vesicle transport along microtubule (GO:0047496) | 2.35190688 |
| 162 | gamma-aminobutyric acid transport (GO:0015812) | 2.35020198 |
| 163 | apoptotic cell clearance (GO:0043277) | 2.34952002 |
| 164 | low-density lipoprotein particle clearance (GO:0034383) | 2.33027183 |
| 165 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.33003049 |
| 166 | antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886) | 2.32858113 |
| 167 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.32017954 |
| 168 | regulation of mast cell activation (GO:0033003) | 2.31874698 |
| 169 | negative regulation of T cell apoptotic process (GO:0070233) | 2.31684490 |
| 170 | cellular response to topologically incorrect protein (GO:0035967) | 2.30835488 |
| 171 | protein localization to endosome (GO:0036010) | 2.30157809 |
| 172 | fucose catabolic process (GO:0019317) | 2.28881139 |
| 173 | L-fucose metabolic process (GO:0042354) | 2.28881139 |
| 174 | L-fucose catabolic process (GO:0042355) | 2.28881139 |
| 175 | barbed-end actin filament capping (GO:0051016) | 2.28581950 |
| 176 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:000250 | 2.27738727 |
| 177 | antigen processing and presentation of peptide antigen via MHC class II (GO:0002495) | 2.27738727 |
| 178 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.27525529 |
| 179 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.27265864 |
| 180 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.27237053 |
| 181 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.27170027 |
| 182 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.26268427 |
| 183 | muscle cell cellular homeostasis (GO:0046716) | 2.25858773 |
| 184 | beta-amyloid metabolic process (GO:0050435) | 2.25783217 |
| 185 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.25607074 |
| 186 | positive regulation of lamellipodium assembly (GO:0010592) | 2.25501521 |
| 187 | gluconeogenesis (GO:0006094) | 2.25306553 |
| 188 | positive regulation of lymphocyte migration (GO:2000403) | 2.25270163 |
| 189 | cellular extravasation (GO:0045123) | 2.24610724 |
| 190 | B cell receptor signaling pathway (GO:0050853) | 2.23487767 |
| 191 | mRNA cleavage (GO:0006379) | 2.22844514 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 6.23210250 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.02255636 |
| 3 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.89922617 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 2.67913585 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.66740004 |
| 6 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.50386703 |
| 7 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.46923807 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.46300202 |
| 9 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.35325646 |
| 10 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.31478597 |
| 11 | GATA1_22025678_ChIP-Seq_K562_Human | 2.21475213 |
| 12 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.19557455 |
| 13 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.17121369 |
| 14 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.13657018 |
| 15 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.08226542 |
| 16 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.07593331 |
| 17 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.99626345 |
| 18 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.97934079 |
| 19 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.94993513 |
| 20 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.87046605 |
| 21 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.84265670 |
| 22 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.84101481 |
| 23 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.83893751 |
| 24 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.83257230 |
| 25 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.80547261 |
| 26 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.80274625 |
| 27 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.79436758 |
| 28 | MAF_26560356_Chip-Seq_TH2_Human | 1.78869720 |
| 29 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.78105664 |
| 30 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.78087975 |
| 31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.77959752 |
| 32 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.77737592 |
| 33 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.77663519 |
| 34 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.76492744 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.74872253 |
| 36 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.73646908 |
| 37 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.73321394 |
| 38 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.72518168 |
| 39 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.71528744 |
| 40 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.71409201 |
| 41 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.71038708 |
| 42 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.71034998 |
| 43 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.69956582 |
| 44 | SPI1_23127762_ChIP-Seq_K562_Human | 1.69515860 |
| 45 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.64212760 |
| 46 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.62505538 |
| 47 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.62247119 |
| 48 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.61834743 |
| 49 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.60494576 |
| 50 | MYB_26560356_Chip-Seq_TH1_Human | 1.58150094 |
| 51 | MYB_26560356_Chip-Seq_TH2_Human | 1.57363910 |
| 52 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.57006308 |
| 53 | KDM2B_26808549_Chip-Seq_K562_Human | 1.55338894 |
| 54 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.53544733 |
| 55 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.50710924 |
| 56 | GATA1_19941826_ChIP-Seq_K562_Human | 1.48379624 |
| 57 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.48071488 |
| 58 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47873601 |
| 59 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.47627762 |
| 60 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.47362585 |
| 61 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.45710840 |
| 62 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.44287752 |
| 63 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.43279080 |
| 64 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.40938775 |
| 65 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.40069843 |
| 66 | P68_20966046_ChIP-Seq_HELA_Human | 1.39873724 |
| 67 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.39409415 |
| 68 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.39397630 |
| 69 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39296982 |
| 70 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.39084508 |
| 71 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.37557312 |
| 72 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.33405611 |
| 73 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.32389066 |
| 74 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.31670157 |
| 75 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.30866738 |
| 76 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.30799928 |
| 77 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.30582678 |
| 78 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.29424588 |
| 79 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.27972271 |
| 80 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.27445470 |
| 81 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.26824896 |
| 82 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.26570373 |
| 83 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.25789730 |
| 84 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.24825379 |
| 85 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.24616487 |
| 86 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.22778872 |
| 87 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.22425273 |
| 88 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.22404287 |
| 89 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21498948 |
| 90 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.20710896 |
| 91 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.20245168 |
| 92 | MAF_26560356_Chip-Seq_TH1_Human | 1.20134723 |
| 93 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20122517 |
| 94 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.18284841 |
| 95 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.17067074 |
| 96 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.16875056 |
| 97 | UTX_26944678_Chip-Seq_JUKART_Human | 1.16581986 |
| 98 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.16417501 |
| 99 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.16010056 |
| 100 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.14851683 |
| 101 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.14612515 |
| 102 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.13323476 |
| 103 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.13297643 |
| 104 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.12812866 |
| 105 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.12562860 |
| 106 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12107602 |
| 107 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11739515 |
| 108 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.11510009 |
| 109 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.11429125 |
| 110 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.11099726 |
| 111 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.11081457 |
| 112 | ERA_21632823_ChIP-Seq_H3396_Human | 1.10592841 |
| 113 | * MITF_21258399_ChIP-Seq_MELANOMA_Human | 1.09186621 |
| 114 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.06798575 |
| 115 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.06670269 |
| 116 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.06647243 |
| 117 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.06015182 |
| 118 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.05050175 |
| 119 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.04505704 |
| 120 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.04163327 |
| 121 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.04145366 |
| 122 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.03809610 |
| 123 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.03341928 |
| 124 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.03307152 |
| 125 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.03159435 |
| 126 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.02739523 |
| 127 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.02634956 |
| 128 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02531497 |
| 129 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.02466979 |
| 130 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.02425723 |
| 131 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01871533 |
| 132 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.01517268 |
| 133 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.01240939 |
| 134 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01008749 |
| 135 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.99752025 |
| 136 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99434156 |
| 137 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.98174945 |
| 138 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.98134217 |
| 139 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.98134004 |
| 140 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.98034066 |
| 141 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.95669431 |
| 142 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.94605124 |
| 143 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.94285454 |
| 144 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.94067546 |
| 145 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.94021286 |
| 146 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.93377512 |
| 147 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92995104 |
| 148 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92676305 |
| 149 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.91040685 |
| 150 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.90739762 |
| 151 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.90191826 |
| 152 | P300_27268052_Chip-Seq_Bcells_Human | 0.89947223 |
| 153 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.89873827 |
| 154 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.89440274 |
| 155 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.88842640 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 3.72609810 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 3.55866959 |
| 3 | MP0008004_abnormal_stomach_pH | 3.54754219 |
| 4 | MP0003172_abnormal_lysosome_physiology | 3.26413383 |
| 5 | MP0003329_amyloid_beta_deposits | 3.15382107 |
| 6 | MP0002909_abnormal_adrenal_gland | 3.02563620 |
| 7 | MP0003763_abnormal_thymus_physiology | 2.92270355 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 2.74649474 |
| 9 | MP0003183_abnormal_peptide_metabolism | 2.70485690 |
| 10 | MP0000604_amyloidosis | 2.69961971 |
| 11 | MP0003436_decreased_susceptibility_to | 2.63971916 |
| 12 | MP0009780_abnormal_chondrocyte_physiolo | 2.58143005 |
| 13 | MP0009840_abnormal_foam_cell | 2.56663497 |
| 14 | MP0002132_abnormal_respiratory_system | 2.51081171 |
| 15 | MP0003724_increased_susceptibility_to | 2.48860243 |
| 16 | MP0001835_abnormal_antigen_presentation | 2.32449079 |
| 17 | MP0000013_abnormal_adipose_tissue | 2.32150007 |
| 18 | MP0008961_abnormal_basal_metabolism | 2.32007453 |
| 19 | MP0005671_abnormal_response_to | 2.26219449 |
| 20 | MP0004381_abnormal_hair_follicle | 2.19090884 |
| 21 | MP0004858_abnormal_nervous_system | 2.18536583 |
| 22 | MP0003635_abnormal_synaptic_transmissio | 2.11527872 |
| 23 | MP0009785_altered_susceptibility_to | 2.09673447 |
| 24 | MP0002822_catalepsy | 2.08543742 |
| 25 | MP0005025_abnormal_response_to | 2.07616327 |
| 26 | MP0002419_abnormal_innate_immunity | 2.05848725 |
| 27 | MP0003300_gastrointestinal_ulcer | 2.03576135 |
| 28 | MP0005387_immune_system_phenotype | 2.02065524 |
| 29 | MP0001790_abnormal_immune_system | 2.02065524 |
| 30 | MP0005000_abnormal_immune_tolerance | 1.97845872 |
| 31 | MP0001800_abnormal_humoral_immune | 1.97025438 |
| 32 | MP0003705_abnormal_hypodermis_morpholog | 1.91837889 |
| 33 | MP0002148_abnormal_hypersensitivity_rea | 1.89637433 |
| 34 | MP0000749_muscle_degeneration | 1.86972736 |
| 35 | MP0003191_abnormal_cellular_cholesterol | 1.84420067 |
| 36 | MP0002064_seizures | 1.83569686 |
| 37 | MP0002420_abnormal_adaptive_immunity | 1.83196355 |
| 38 | MP0001819_abnormal_immune_cell | 1.79564942 |
| 39 | MP0000343_altered_response_to | 1.73690206 |
| 40 | MP0002723_abnormal_immune_serum | 1.73130741 |
| 41 | MP0002452_abnormal_antigen_presenting | 1.72327691 |
| 42 | MP0000003_abnormal_adipose_tissue | 1.71179582 |
| 43 | MP0005410_abnormal_fertilization | 1.71098821 |
| 44 | MP0003303_peritoneal_inflammation | 1.69860236 |
| 45 | MP0004130_abnormal_muscle_cell | 1.68435466 |
| 46 | MP0002653_abnormal_ependyma_morphology | 1.68327554 |
| 47 | MP0003315_abnormal_perineum_morphology | 1.68308801 |
| 48 | MP0003690_abnormal_glial_cell | 1.65154751 |
| 49 | MP0005166_decreased_susceptibility_to | 1.61460760 |
| 50 | MP0003828_pulmonary_edema | 1.59039227 |
| 51 | MP0003633_abnormal_nervous_system | 1.53996763 |
| 52 | MP0010386_abnormal_urinary_bladder | 1.53562253 |
| 53 | MP0004885_abnormal_endolymph | 1.51253158 |
| 54 | MP0000465_gastrointestinal_hemorrhage | 1.50851173 |
| 55 | MP0003075_altered_response_to | 1.46151763 |
| 56 | MP0002998_abnormal_bone_remodeling | 1.45355862 |
| 57 | MP0009278_abnormal_bone_marrow | 1.44653253 |
| 58 | MP0002063_abnormal_learning/memory/cond | 1.43966578 |
| 59 | MP0010329_abnormal_lipoprotein_level | 1.41941291 |
| 60 | MP0002405_respiratory_system_inflammati | 1.40146264 |
| 61 | MP0009046_muscle_twitch | 1.39104743 |
| 62 | MP0000015_abnormal_ear_pigmentation | 1.36646237 |
| 63 | MP0008569_lethality_at_weaning | 1.36361810 |
| 64 | MP0005365_abnormal_bile_salt | 1.35948366 |
| 65 | MP0004043_abnormal_pH_regulation | 1.34711868 |
| 66 | MP0004270_analgesia | 1.32288147 |
| 67 | MP0000716_abnormal_immune_system | 1.30901211 |
| 68 | MP0001756_abnormal_urination | 1.30223726 |
| 69 | MP0003656_abnormal_erythrocyte_physiolo | 1.27833073 |
| 70 | MP0009745_abnormal_behavioral_response | 1.27774875 |
| 71 | MP0001845_abnormal_inflammatory_respons | 1.27774050 |
| 72 | MP0004233_abnormal_muscle_weight | 1.27605488 |
| 73 | MP0002166_altered_tumor_susceptibility | 1.25453629 |
| 74 | MP0002139_abnormal_hepatobiliary_system | 1.24126186 |
| 75 | MP0005451_abnormal_body_composition | 1.23727061 |
| 76 | MP0000569_abnormal_digit_pigmentation | 1.22765782 |
| 77 | MP0002078_abnormal_glucose_homeostasis | 1.22366366 |
| 78 | MP0003634_abnormal_glial_cell | 1.21047469 |
| 79 | MP0002398_abnormal_bone_marrow | 1.20231350 |
| 80 | MP0010155_abnormal_intestine_physiology | 1.19768772 |
| 81 | MP0000703_abnormal_thymus_morphology | 1.17748889 |
| 82 | MP0001533_abnormal_skeleton_physiology | 1.16042989 |
| 83 | MP0005375_adipose_tissue_phenotype | 1.13977082 |
| 84 | MP0004811_abnormal_neuron_physiology | 1.13543544 |
| 85 | MP0001664_abnormal_digestion | 1.13141631 |
| 86 | MP0001502_abnormal_circadian_rhythm | 1.13038398 |
| 87 | MP0003879_abnormal_hair_cell | 1.12863863 |
| 88 | MP0003631_nervous_system_phenotype | 1.11902493 |
| 89 | MP0001873_stomach_inflammation | 1.09794589 |
| 90 | MP0002572_abnormal_emotion/affect_behav | 1.09544991 |
| 91 | MP0000609_abnormal_liver_physiology | 1.08960458 |
| 92 | MP0005397_hematopoietic_system_phenotyp | 1.08405288 |
| 93 | MP0001545_abnormal_hematopoietic_system | 1.08405288 |
| 94 | MP0003195_calcinosis | 1.08375215 |
| 95 | MP0008260_abnormal_autophagy | 1.07290347 |
| 96 | MP0010352_gastrointestinal_tract_polyps | 1.07231668 |
| 97 | MP0002722_abnormal_immune_system | 1.07207141 |
| 98 | MP0009333_abnormal_splenocyte_physiolog | 1.06994078 |
| 99 | MP0005646_abnormal_pituitary_gland | 1.06325752 |
| 100 | MP0003045_fibrosis | 1.06235159 |
| 101 | MP0002733_abnormal_thermal_nociception | 1.05893711 |
| 102 | MP0005535_abnormal_body_temperature | 1.04521528 |
| 103 | MP0005174_abnormal_tail_pigmentation | 1.03181107 |
| 104 | MP0005464_abnormal_platelet_physiology | 1.02392639 |
| 105 | MP0004484_altered_response_of | 1.02218141 |
| 106 | MP0003646_muscle_fatigue | 1.02133933 |
| 107 | MP0002118_abnormal_lipid_homeostasis | 1.01418095 |
| 108 | MP0009764_decreased_sensitivity_to | 1.00805222 |
| 109 | MP0002877_abnormal_melanocyte_morpholog | 1.00489117 |
| 110 | MP0004036_abnormal_muscle_relaxation | 1.00455399 |
| 111 | MP0002160_abnormal_reproductive_system | 1.00339789 |
| 112 | MP0002933_joint_inflammation | 1.00220410 |
| 113 | MP0008469_abnormal_protein_level | 0.98701823 |
| 114 | MP0000920_abnormal_myelination | 0.98402933 |
| 115 | MP0005670_abnormal_white_adipose | 0.97841151 |
| 116 | MP0004084_abnormal_cardiac_muscle | 0.97279088 |
| 117 | MP0002837_dystrophic_cardiac_calcinosis | 0.96423576 |
| 118 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.95650108 |
| 119 | MP0005310_abnormal_salivary_gland | 0.94904033 |
| 120 | MP0002693_abnormal_pancreas_physiology | 0.94900893 |
| 121 | MP0005332_abnormal_amino_acid | 0.93944915 |
| 122 | MP0000681_abnormal_thyroid_gland | 0.93943587 |
| 123 | MP0006036_abnormal_mitochondrial_physio | 0.93594439 |
| 124 | MP0003866_abnormal_defecation | 0.92793090 |
| 125 | MP0002429_abnormal_blood_cell | 0.92428555 |
| 126 | MP0000689_abnormal_spleen_morphology | 0.92396739 |
| 127 | MP0003632_abnormal_nervous_system | 0.92099141 |
| 128 | MP0000678_abnormal_parathyroid_gland | 0.91899332 |
| 129 | MP0002089_abnormal_postnatal_growth/wei | 0.91114678 |
| 130 | MP0002090_abnormal_vision | 0.89292130 |
| 131 | MP0002229_neurodegeneration | 0.88243182 |
| 132 | MP0004185_abnormal_adipocyte_glucose | 0.87467699 |
| 133 | MP0002272_abnormal_nervous_system | 0.86866504 |
| 134 | MP0003566_abnormal_cell_adhesion | 0.86738936 |
| 135 | MP0000371_diluted_coat_color | 0.86579743 |
| 136 | MP0005448_abnormal_energy_balance | 0.84183912 |
| 137 | MP0002138_abnormal_hepatobiliary_system | 0.83990872 |
| 138 | MP0005647_abnormal_sex_gland | 0.83881651 |
| 139 | MP0004947_skin_inflammation | 0.82393441 |
| 140 | MP0005075_abnormal_melanosome_morpholog | 0.82366122 |
| 141 | MP0001905_abnormal_dopamine_level | 0.81303760 |
| 142 | MP0008874_decreased_physiological_sensi | 0.81119903 |
| 143 | MP0002067_abnormal_sensory_capabilities | 0.80937475 |
| 144 | MP0004883_abnormal_blood_vessel | 0.80864779 |
| 145 | MP0005076_abnormal_cell_differentiation | 0.78815182 |
| 146 | MP0003136_yellow_coat_color | 0.78631269 |
| 147 | MP0001501_abnormal_sleep_pattern | 0.77714092 |
| 148 | MP0001944_abnormal_pancreas_morphology | 0.76736577 |
| 149 | MP0001970_abnormal_pain_threshold | 0.76708375 |
| 150 | MP0005164_abnormal_response_to | 0.76541833 |
| 151 | MP0001440_abnormal_grooming_behavior | 0.76218692 |
| 152 | MP0005360_urolithiasis | 0.75888064 |
| 153 | MP0003953_abnormal_hormone_level | 0.75183325 |
| 154 | MP0009643_abnormal_urine_homeostasis | 0.75078576 |
| 155 | MP0006082_CNS_inflammation | 0.74561934 |
| 156 | MP0005666_abnormal_adipose_tissue | 0.73493623 |
| 157 | MP0001968_abnormal_touch/_nociception | 0.73464626 |
| 158 | MP0002332_abnormal_exercise_endurance | 0.73421706 |
| 159 | MP0005319_abnormal_enzyme/_coenzyme | 0.73327344 |
| 160 | MP0004510_myositis | 0.73303834 |
| 161 | MP0001958_emphysema | 0.73142846 |
| 162 | MP0001853_heart_inflammation | 0.73086851 |
| 163 | MP0003795_abnormal_bone_structure | 0.72773167 |
| 164 | MP0000955_abnormal_spinal_cord | 0.72356582 |
| 165 | MP0001764_abnormal_homeostasis | 0.72338836 |
| 166 | MP0001849_ear_inflammation | 0.72298362 |
| 167 | MP0000747_muscle_weakness | 0.72096721 |
| 168 | MP0002069_abnormal_eating/drinking_beha | 0.72011975 |
| 169 | MP0005334_abnormal_fat_pad | 0.71307167 |
| 170 | MP0002066_abnormal_motor_capabilities/c | 0.71007910 |
| 171 | MP0001765_abnormal_ion_homeostasis | 0.70699735 |
| 172 | MP0003283_abnormal_digestive_organ | 0.70512609 |
| 173 | MP0010307_abnormal_tumor_latency | 0.70481397 |
| 174 | MP0005167_abnormal_blood-brain_barrier | 0.69867184 |
| 175 | MP0000685_abnormal_immune_system | 0.68692602 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the columella (HP:0009929) | 5.68419306 |
| 2 | Increased cerebral lipofuscin (HP:0011813) | 4.21526924 |
| 3 | Thoracic kyphosis (HP:0002942) | 3.94795463 |
| 4 | Abnormality of the lower motor neuron (HP:0002366) | 3.76564022 |
| 5 | Eosinophilia (HP:0001880) | 3.52970404 |
| 6 | Visual hallucinations (HP:0002367) | 3.52162850 |
| 7 | Reduced antithrombin III activity (HP:0001976) | 3.42741128 |
| 8 | Dysostosis multiplex (HP:0000943) | 3.40003012 |
| 9 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.37932201 |
| 10 | Granulocytopenia (HP:0001913) | 3.28066729 |
| 11 | Hyporeflexia of lower limbs (HP:0002600) | 3.26323936 |
| 12 | Colitis (HP:0002583) | 3.22397025 |
| 13 | Exercise-induced myalgia (HP:0003738) | 3.18800686 |
| 14 | Supranuclear gaze palsy (HP:0000605) | 3.16638925 |
| 15 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 3.13448647 |
| 16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.06234988 |
| 17 | Resting tremor (HP:0002322) | 3.05021689 |
| 18 | Ventricular fibrillation (HP:0001663) | 3.03109125 |
| 19 | Eczematoid dermatitis (HP:0000976) | 3.01656902 |
| 20 | Myositis (HP:0100614) | 2.99545659 |
| 21 | Abnormality of macrophages (HP:0004311) | 2.96706800 |
| 22 | Clumsiness (HP:0002312) | 2.96614232 |
| 23 | Global brain atrophy (HP:0002283) | 2.95532577 |
| 24 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.95176168 |
| 25 | Inflammation of the large intestine (HP:0002037) | 2.93318768 |
| 26 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.92193411 |
| 27 | Autoimmune thrombocytopenia (HP:0001973) | 2.90660944 |
| 28 | Hand muscle atrophy (HP:0009130) | 2.86865882 |
| 29 | Abnormality of glycolipid metabolism (HP:0010969) | 2.86785948 |
| 30 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.86785948 |
| 31 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.86785948 |
| 32 | Focal motor seizures (HP:0011153) | 2.80716371 |
| 33 | Dysmetric saccades (HP:0000641) | 2.78364171 |
| 34 | Gastrointestinal inflammation (HP:0004386) | 2.77925682 |
| 35 | Pustule (HP:0200039) | 2.76022355 |
| 36 | Recurrent fungal infections (HP:0002841) | 2.75886231 |
| 37 | Mucopolysacchariduria (HP:0008155) | 2.70074622 |
| 38 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.70074622 |
| 39 | Depression (HP:0000716) | 2.67187300 |
| 40 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.62547005 |
| 41 | Upper limb amyotrophy (HP:0009129) | 2.62205899 |
| 42 | Distal upper limb amyotrophy (HP:0007149) | 2.62205899 |
| 43 | Ketoacidosis (HP:0001993) | 2.60967453 |
| 44 | Abnormality of the thoracic spine (HP:0100711) | 2.60943416 |
| 45 | Orchitis (HP:0100796) | 2.60487007 |
| 46 | Stomatitis (HP:0010280) | 2.59686134 |
| 47 | Focal seizures (HP:0007359) | 2.59126850 |
| 48 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.58195264 |
| 49 | Hypoglycemic seizures (HP:0002173) | 2.56810151 |
| 50 | Abnormality of eosinophils (HP:0001879) | 2.55771191 |
| 51 | Abnormality of the frontal sinuses (HP:0002687) | 2.53297087 |
| 52 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.51999207 |
| 53 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.51999207 |
| 54 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.51999207 |
| 55 | Cerebral inclusion bodies (HP:0100314) | 2.51689942 |
| 56 | Axonal loss (HP:0003447) | 2.51497953 |
| 57 | Neuronal loss in central nervous system (HP:0002529) | 2.49459613 |
| 58 | Easy fatigability (HP:0003388) | 2.48497740 |
| 59 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.48496190 |
| 60 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.48496190 |
| 61 | Upper motor neuron abnormality (HP:0002127) | 2.45461753 |
| 62 | Recurrent bacterial skin infections (HP:0005406) | 2.42245190 |
| 63 | Leukocytosis (HP:0001974) | 2.40478857 |
| 64 | Abnormality of lateral ventricle (HP:0030047) | 2.40312102 |
| 65 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.38742786 |
| 66 | Vacuolated lymphocytes (HP:0001922) | 2.38642694 |
| 67 | Recurrent abscess formation (HP:0002722) | 2.38108559 |
| 68 | Postural tremor (HP:0002174) | 2.34691129 |
| 69 | Retinal atrophy (HP:0001105) | 2.34462074 |
| 70 | Truncal ataxia (HP:0002078) | 2.33623162 |
| 71 | Optic neuritis (HP:0100653) | 2.31620198 |
| 72 | Retrobulbar optic neuritis (HP:0100654) | 2.31620198 |
| 73 | Cerebral aneurysm (HP:0004944) | 2.29477707 |
| 74 | Loss of speech (HP:0002371) | 2.27719599 |
| 75 | Autoimmune hemolytic anemia (HP:0001890) | 2.24730002 |
| 76 | Obstructive lung disease (HP:0006536) | 2.23301140 |
| 77 | Chronic obstructive pulmonary disease (HP:0006510) | 2.23301140 |
| 78 | Impaired smooth pursuit (HP:0007772) | 2.22761186 |
| 79 | J-shaped sella turcica (HP:0002680) | 2.22177527 |
| 80 | Panhypogammaglobulinemia (HP:0003139) | 2.20098704 |
| 81 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.19027473 |
| 82 | Absent/shortened dynein arms (HP:0200106) | 2.19027473 |
| 83 | Pheochromocytoma (HP:0002666) | 2.18147771 |
| 84 | Abnormality of the periventricular white matter (HP:0002518) | 2.16656803 |
| 85 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.16608350 |
| 86 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.14851183 |
| 87 | Ankle clonus (HP:0011448) | 2.14351443 |
| 88 | Urinary urgency (HP:0000012) | 2.13943643 |
| 89 | Ocular albinism (HP:0001107) | 2.13225507 |
| 90 | Unsteady gait (HP:0002317) | 2.12119955 |
| 91 | Generalized tonic-clonic seizures (HP:0002069) | 2.11908457 |
| 92 | Recurrent cutaneous fungal infections (HP:0011370) | 2.11660258 |
| 93 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.11660258 |
| 94 | Hematochezia (HP:0002573) | 2.10348958 |
| 95 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.08060887 |
| 96 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.07352325 |
| 97 | Vasculitis (HP:0002633) | 2.06855567 |
| 98 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.06337089 |
| 99 | Neurofibrillary tangles (HP:0002185) | 2.05782861 |
| 100 | Meningitis (HP:0001287) | 2.05311091 |
| 101 | Postural instability (HP:0002172) | 2.04357607 |
| 102 | Hemiplegia (HP:0002301) | 2.02826089 |
| 103 | Abnormality of T cell number (HP:0011839) | 2.02777779 |
| 104 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.02406395 |
| 105 | Spastic gait (HP:0002064) | 2.02190184 |
| 106 | Spinal rigidity (HP:0003306) | 2.01672431 |
| 107 | Myokymia (HP:0002411) | 2.01209585 |
| 108 | Recurrent viral infections (HP:0004429) | 2.00992918 |
| 109 | Lip pit (HP:0100267) | 2.00713635 |
| 110 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.00657090 |
| 111 | Neoplasm of the heart (HP:0100544) | 2.00171253 |
| 112 | Abnormality of the nasal mucosa (HP:0000433) | 2.00088020 |
| 113 | Absence seizures (HP:0002121) | 2.00068727 |
| 114 | Gout (HP:0001997) | 1.99087253 |
| 115 | Self-mutilation (HP:0000742) | 1.98066295 |
| 116 | Poor head control (HP:0002421) | 1.97465223 |
| 117 | Gonadal dysgenesis (HP:0000133) | 1.96847033 |
| 118 | Amyotrophic lateral sclerosis (HP:0007354) | 1.96267097 |
| 119 | Impaired social interactions (HP:0000735) | 1.96129603 |
| 120 | Abnormal social behavior (HP:0012433) | 1.96129603 |
| 121 | Insomnia (HP:0100785) | 1.95388194 |
| 122 | Large for gestational age (HP:0001520) | 1.95188451 |
| 123 | Cerebellar dysplasia (HP:0007033) | 1.94586121 |
| 124 | Type II lissencephaly (HP:0007260) | 1.93588744 |
| 125 | Death in childhood (HP:0003819) | 1.93154360 |
| 126 | Ketosis (HP:0001946) | 1.92837108 |
| 127 | Mediastinal lymphadenopathy (HP:0100721) | 1.92330931 |
| 128 | Prolonged QT interval (HP:0001657) | 1.92102541 |
| 129 | Abnormal ciliary motility (HP:0012262) | 1.90840873 |
| 130 | Decreased circulating renin level (HP:0003351) | 1.90556475 |
| 131 | Enlarged penis (HP:0000040) | 1.90386755 |
| 132 | Abnormality of the motor neurons (HP:0002450) | 1.90038912 |
| 133 | Abnormal neuron morphology (HP:0012757) | 1.90038912 |
| 134 | Increased CSF protein (HP:0002922) | 1.89776863 |
| 135 | Diaphragmatic weakness (HP:0009113) | 1.89450320 |
| 136 | Oligomenorrhea (HP:0000876) | 1.89348235 |
| 137 | Hypoglycemic coma (HP:0001325) | 1.88499390 |
| 138 | Bulbar palsy (HP:0001283) | 1.87710951 |
| 139 | Progressive neurologic deterioration (HP:0002344) | 1.87354001 |
| 140 | Increased variability in muscle fiber diameter (HP:0003557) | 1.85883574 |
| 141 | Neuroendocrine neoplasm (HP:0100634) | 1.85755716 |
| 142 | Spastic tetraparesis (HP:0001285) | 1.85690199 |
| 143 | Nasal polyposis (HP:0100582) | 1.84365363 |
| 144 | Cholelithiasis (HP:0001081) | 1.83372181 |
| 145 | Hypsarrhythmia (HP:0002521) | 1.82453622 |
| 146 | Clonus (HP:0002169) | 1.82065355 |
| 147 | Macroorchidism (HP:0000053) | 1.81747774 |
| 148 | Recurrent skin infections (HP:0001581) | 1.81571334 |
| 149 | T lymphocytopenia (HP:0005403) | 1.81472377 |
| 150 | Abnormality of T cells (HP:0002843) | 1.80992658 |
| 151 | Gastrointestinal infarctions (HP:0005244) | 1.80924846 |
| 152 | EEG with generalized epileptiform discharges (HP:0011198) | 1.80730244 |
| 153 | Papilledema (HP:0001085) | 1.80196145 |
| 154 | Epileptiform EEG discharges (HP:0011182) | 1.80031961 |
| 155 | Hypokalemic alkalosis (HP:0001949) | 1.79510257 |
| 156 | Epileptic encephalopathy (HP:0200134) | 1.79451299 |
| 157 | Dementia (HP:0000726) | 1.79245794 |
| 158 | Spinal muscular atrophy (HP:0007269) | 1.79029658 |
| 159 | Prolonged bleeding time (HP:0003010) | 1.78815941 |
| 160 | Petechiae (HP:0000967) | 1.78636244 |
| 161 | Polyneuropathy (HP:0001271) | 1.78592684 |
| 162 | Dialeptic seizures (HP:0011146) | 1.78203261 |
| 163 | Growth hormone excess (HP:0000845) | 1.77803085 |
| 164 | Frequent falls (HP:0002359) | 1.76747755 |
| 165 | Calf muscle hypertrophy (HP:0008981) | 1.76518240 |
| 166 | Spontaneous hematomas (HP:0007420) | 1.76504846 |
| 167 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.76384008 |
| 168 | Striae distensae (HP:0001065) | 1.76125746 |
| 169 | Abnormal gallbladder morphology (HP:0012437) | 1.75971716 |
| 170 | Hyperglycemia (HP:0003074) | 1.75916344 |
| 171 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.73845793 |
| 172 | Abnormal eating behavior (HP:0100738) | 1.73146936 |
| 173 | Conjugated hyperbilirubinemia (HP:0002908) | 1.71507547 |
| 174 | Abnormality of saccadic eye movements (HP:0000570) | 1.71276621 |
| 175 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.70561760 |
| 176 | Apathy (HP:0000741) | 1.68585118 |
| 177 | Rapidly progressive (HP:0003678) | 1.67940411 |
| 178 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.67873460 |
| 179 | Long toe (HP:0010511) | 1.66977725 |
| 180 | Interstitial pulmonary disease (HP:0006530) | 1.66887505 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PINK1 | 6.84255879 |
| 2 | MARK3 | 4.69301027 |
| 3 | TRIB3 | 4.42060813 |
| 4 | INSRR | 3.16951994 |
| 5 | TLK1 | 2.76442650 |
| 6 | CAMKK1 | 2.47988392 |
| 7 | ERN1 | 2.42752349 |
| 8 | PKN2 | 2.30264278 |
| 9 | PASK | 2.25969659 |
| 10 | MAP3K9 | 2.13378533 |
| 11 | SCYL2 | 2.10275910 |
| 12 | TNK2 | 2.05619012 |
| 13 | DAPK2 | 1.94891281 |
| 14 | LMTK2 | 1.89308735 |
| 15 | KSR2 | 1.81846011 |
| 16 | FGFR4 | 1.80929421 |
| 17 | MAP3K4 | 1.76218337 |
| 18 | NTRK3 | 1.75766510 |
| 19 | RET | 1.64964062 |
| 20 | NME2 | 1.58355227 |
| 21 | DAPK1 | 1.57063925 |
| 22 | NTRK1 | 1.56382654 |
| 23 | MAP2K4 | 1.53191024 |
| 24 | FRK | 1.47080067 |
| 25 | MAPK12 | 1.46788999 |
| 26 | GRK6 | 1.45575525 |
| 27 | TAOK1 | 1.44531547 |
| 28 | PDK4 | 1.43981884 |
| 29 | PDK3 | 1.43981884 |
| 30 | TSSK6 | 1.41721841 |
| 31 | OBSCN | 1.41383674 |
| 32 | MYLK | 1.40745411 |
| 33 | BTK | 1.37941696 |
| 34 | LATS1 | 1.37091797 |
| 35 | MAP3K2 | 1.35836647 |
| 36 | MAP3K12 | 1.35256215 |
| 37 | PDGFRA | 1.34897889 |
| 38 | EEF2K | 1.33637079 |
| 39 | SIK1 | 1.31583009 |
| 40 | PTK6 | 1.30421944 |
| 41 | ICK | 1.29848660 |
| 42 | NEK2 | 1.29340237 |
| 43 | JAK1 | 1.28999340 |
| 44 | PRKCH | 1.28642749 |
| 45 | CAMKK2 | 1.26848135 |
| 46 | PAK6 | 1.25901099 |
| 47 | MAP4K1 | 1.25639487 |
| 48 | PRPF4B | 1.25572295 |
| 49 | BCKDK | 1.19987610 |
| 50 | BLK | 1.18335264 |
| 51 | MINK1 | 1.17430777 |
| 52 | MAP3K3 | 1.16617391 |
| 53 | ALK | 1.15408539 |
| 54 | ZAP70 | 1.15146948 |
| 55 | PRKCQ | 1.13648580 |
| 56 | RIPK4 | 1.12703192 |
| 57 | TYK2 | 1.11690494 |
| 58 | PAK4 | 1.07925430 |
| 59 | MAP3K13 | 1.07311817 |
| 60 | TYRO3 | 1.07099181 |
| 61 | MAPKAPK3 | 1.06679081 |
| 62 | SGK3 | 1.03546849 |
| 63 | MOS | 1.03426856 |
| 64 | MAP2K3 | 1.03188612 |
| 65 | ARAF | 1.01712213 |
| 66 | PRKD3 | 1.00446431 |
| 67 | TAOK3 | 0.99277595 |
| 68 | NEK1 | 0.99173919 |
| 69 | SIK2 | 0.98591501 |
| 70 | ZAK | 0.96043139 |
| 71 | CSNK1A1L | 0.95295878 |
| 72 | JAK2 | 0.92710609 |
| 73 | EPHB1 | 0.91937706 |
| 74 | RIPK1 | 0.91780889 |
| 75 | RPS6KA5 | 0.88688198 |
| 76 | NLK | 0.88669668 |
| 77 | MELK | 0.88532198 |
| 78 | CDK3 | 0.87434871 |
| 79 | MAP2K7 | 0.87341614 |
| 80 | CSNK1G3 | 0.87262846 |
| 81 | FGFR3 | 0.84075292 |
| 82 | MAP3K1 | 0.83102116 |
| 83 | TXK | 0.79835387 |
| 84 | PDK1 | 0.79600329 |
| 85 | CDK12 | 0.79332950 |
| 86 | CDK5 | 0.78429258 |
| 87 | STK38 | 0.78158014 |
| 88 | TESK1 | 0.77691517 |
| 89 | IKBKE | 0.75524957 |
| 90 | CDK19 | 0.75463013 |
| 91 | IRAK2 | 0.74395972 |
| 92 | TBK1 | 0.72737647 |
| 93 | LRRK2 | 0.72351261 |
| 94 | NTRK2 | 0.71641575 |
| 95 | PDPK1 | 0.70997286 |
| 96 | TESK2 | 0.70312594 |
| 97 | ITK | 0.68657008 |
| 98 | CSK | 0.67960440 |
| 99 | MAPK15 | 0.66338403 |
| 100 | IRAK4 | 0.65805466 |
| 101 | TTN | 0.65733640 |
| 102 | MAP2K6 | 0.65653051 |
| 103 | CAMK1D | 0.65556023 |
| 104 | MARK2 | 0.64275690 |
| 105 | RPS6KB1 | 0.63625355 |
| 106 | HIPK2 | 0.63368676 |
| 107 | BMX | 0.62788963 |
| 108 | SGK223 | 0.62192169 |
| 109 | SGK494 | 0.62192169 |
| 110 | EPHA3 | 0.62173579 |
| 111 | EPHA4 | 0.61453930 |
| 112 | FES | 0.60633003 |
| 113 | IKBKB | 0.60319691 |
| 114 | MAP3K10 | 0.60286956 |
| 115 | CSF1R | 0.60066417 |
| 116 | BRD4 | 0.59421267 |
| 117 | SGK2 | 0.59189258 |
| 118 | MUSK | 0.59052320 |
| 119 | PDK2 | 0.58746034 |
| 120 | RPS6KA2 | 0.58301776 |
| 121 | PRKG2 | 0.57860345 |
| 122 | PTK2B | 0.56723393 |
| 123 | FGR | 0.56622446 |
| 124 | PTK2 | 0.55301398 |
| 125 | KIT | 0.54742349 |
| 126 | MAP3K7 | 0.54527550 |
| 127 | PIK3CA | 0.53276152 |
| 128 | TRPM7 | 0.53219711 |
| 129 | FLT3 | 0.52625980 |
| 130 | RPS6KL1 | 0.52568242 |
| 131 | RPS6KC1 | 0.52568242 |
| 132 | CSNK1G2 | 0.52533203 |
| 133 | KSR1 | 0.50750618 |
| 134 | PLK2 | 0.50313206 |
| 135 | LCK | 0.50164445 |
| 136 | CAMK1 | 0.50088949 |
| 137 | HCK | 0.49496656 |
| 138 | CDC42BPA | 0.48514570 |
| 139 | RPS6KA6 | 0.48434672 |
| 140 | SYK | 0.48287551 |
| 141 | GRK5 | 0.47974668 |
| 142 | MAP3K5 | 0.47875045 |
| 143 | MTOR | 0.45324349 |
| 144 | PAK1 | 0.43238033 |
| 145 | DAPK3 | 0.42866660 |
| 146 | PRKAA1 | 0.42281581 |
| 147 | PHKG2 | 0.42069194 |
| 148 | PHKG1 | 0.42069194 |
| 149 | MAPK11 | 0.41823285 |
| 150 | PDGFRB | 0.40084867 |
| 151 | CAMK4 | 0.39749793 |
| 152 | CAMK1G | 0.39313544 |
| 153 | PRKCG | 0.39193322 |
| 154 | FYN | 0.38793157 |
| 155 | JAK3 | 0.37771778 |
| 156 | WNK1 | 0.37592335 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.97432917 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.71272061 |
| 3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.68590158 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.44970915 |
| 5 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.21069746 |
| 6 | Lysosome_Homo sapiens_hsa04142 | 2.18285455 |
| 7 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.97274204 |
| 8 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.95913751 |
| 9 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.91336434 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 1.91136837 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.88154095 |
| 12 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.85169291 |
| 13 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.82365081 |
| 14 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.81556795 |
| 15 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.64250825 |
| 16 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.59433784 |
| 17 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.57562761 |
| 18 | Insulin secretion_Homo sapiens_hsa04911 | 1.55849560 |
| 19 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.52484618 |
| 20 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.51361843 |
| 21 | Apoptosis_Homo sapiens_hsa04210 | 1.47919526 |
| 22 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.47328134 |
| 23 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.47317764 |
| 24 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.46927164 |
| 25 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.45577648 |
| 26 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.40552009 |
| 27 | Olfactory transduction_Homo sapiens_hsa04740 | 1.37397586 |
| 28 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.36661482 |
| 29 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.36577168 |
| 30 | Leishmaniasis_Homo sapiens_hsa05140 | 1.36539586 |
| 31 | Malaria_Homo sapiens_hsa05144 | 1.35741553 |
| 32 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.34135911 |
| 33 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.32478500 |
| 34 | GABAergic synapse_Homo sapiens_hsa04727 | 1.31031279 |
| 35 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.29467248 |
| 36 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.28235621 |
| 37 | Long-term potentiation_Homo sapiens_hsa04720 | 1.27786684 |
| 38 | Other glycan degradation_Homo sapiens_hsa00511 | 1.26329757 |
| 39 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.25637881 |
| 40 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.23840907 |
| 41 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.22780161 |
| 42 | Measles_Homo sapiens_hsa05162 | 1.14843081 |
| 43 | Insulin resistance_Homo sapiens_hsa04931 | 1.14290421 |
| 44 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.13888424 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.12963439 |
| 46 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.11881733 |
| 47 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.10426722 |
| 48 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.07459429 |
| 49 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.06785675 |
| 50 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.06719206 |
| 51 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.05883191 |
| 52 | Circadian entrainment_Homo sapiens_hsa04713 | 1.05647980 |
| 53 | Carbon metabolism_Homo sapiens_hsa01200 | 1.01639634 |
| 54 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.01087788 |
| 55 | Pertussis_Homo sapiens_hsa05133 | 1.00441198 |
| 56 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.00341154 |
| 57 | Morphine addiction_Homo sapiens_hsa05032 | 0.99890777 |
| 58 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.99496448 |
| 59 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.99371179 |
| 60 | Glioma_Homo sapiens_hsa05214 | 0.99322016 |
| 61 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.98223361 |
| 62 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.98109725 |
| 63 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.97438276 |
| 64 | Asthma_Homo sapiens_hsa05310 | 0.97308218 |
| 65 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.96261362 |
| 66 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.94528579 |
| 67 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.93992645 |
| 68 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.92392609 |
| 69 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.92184248 |
| 70 | Salivary secretion_Homo sapiens_hsa04970 | 0.91850716 |
| 71 | Hepatitis B_Homo sapiens_hsa05161 | 0.90671099 |
| 72 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.90202283 |
| 73 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.90103160 |
| 74 | Influenza A_Homo sapiens_hsa05164 | 0.89601060 |
| 75 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.89573657 |
| 76 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.89439253 |
| 77 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.89331572 |
| 78 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.88836126 |
| 79 | Bile secretion_Homo sapiens_hsa04976 | 0.88170660 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.87894298 |
| 81 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.87039464 |
| 82 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.85783953 |
| 83 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.85584400 |
| 84 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.85166091 |
| 85 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.84713304 |
| 86 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.82915079 |
| 87 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.82325283 |
| 88 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.81871644 |
| 89 | Renin secretion_Homo sapiens_hsa04924 | 0.81395690 |
| 90 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.81228678 |
| 91 | Cocaine addiction_Homo sapiens_hsa05030 | 0.81125106 |
| 92 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.78335372 |
| 93 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.77828649 |
| 94 | Platelet activation_Homo sapiens_hsa04611 | 0.77637576 |
| 95 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.77586786 |
| 96 | Endocytosis_Homo sapiens_hsa04144 | 0.76673880 |
| 97 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.76366309 |
| 98 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.76247543 |
| 99 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.74992838 |
| 100 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.74446496 |
| 101 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.73528805 |
| 102 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73373299 |
| 103 | Galactose metabolism_Homo sapiens_hsa00052 | 0.71947902 |
| 104 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.71890698 |
| 105 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.71739698 |
| 106 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.71686615 |
| 107 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.71526453 |
| 108 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.70953781 |
| 109 | Prion diseases_Homo sapiens_hsa05020 | 0.70935723 |
| 110 | Legionellosis_Homo sapiens_hsa05134 | 0.70764193 |
| 111 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.70392710 |
| 112 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.69594968 |
| 113 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.69029542 |
| 114 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.67933857 |
| 115 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.67507384 |
| 116 | Taste transduction_Homo sapiens_hsa04742 | 0.67249154 |
| 117 | Hepatitis C_Homo sapiens_hsa05160 | 0.65016628 |
| 118 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.64587681 |
| 119 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.64408590 |
| 120 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.64350380 |
| 121 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.62927753 |
| 122 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.62744745 |
| 123 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.62190228 |
| 124 | ABC transporters_Homo sapiens_hsa02010 | 0.61792182 |
| 125 | Tuberculosis_Homo sapiens_hsa05152 | 0.61747004 |
| 126 | Circadian rhythm_Homo sapiens_hsa04710 | 0.60531721 |
| 127 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.59209686 |
| 128 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.59079748 |
| 129 | Nicotine addiction_Homo sapiens_hsa05033 | 0.58695963 |
| 130 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.58301846 |
| 131 | Phagosome_Homo sapiens_hsa04145 | 0.55662684 |
| 132 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.55396917 |
| 133 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.54963351 |
| 134 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.54562879 |
| 135 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.54239726 |
| 136 | Viral myocarditis_Homo sapiens_hsa05416 | 0.54022743 |
| 137 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.53645282 |
| 138 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.53525169 |
| 139 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.53256388 |
| 140 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.53095443 |
| 141 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.52725502 |
| 142 | Endometrial cancer_Homo sapiens_hsa05213 | 0.51832481 |
| 143 | Gap junction_Homo sapiens_hsa04540 | 0.51581044 |
| 144 | Alcoholism_Homo sapiens_hsa05034 | 0.51221789 |
| 145 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.50391611 |
| 146 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.50141476 |
| 147 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.50069658 |
| 148 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.49573798 |
| 149 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.49381320 |
| 150 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.49114316 |
| 151 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.48060913 |
| 152 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.43298827 |

